Inhalerx Ltd (IRX) — Cash Flow Reinvestment Rate
Latest as of June 2025:
0.00x
Inhalerx Ltd (IRX) has a Cash Flow Reinvestment Rate of 0.00x as of June 2025, reinvesting AU$0.00 (capex AU$0.00 ) from operating cash flow of AU$38.91K. Explore IRX cash flow metrics to assess how effectively this company generates cash.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
AU$0.00
Capex + Investments
Operating Cash Flow
AU$38.91K
AUD
Capital Expenditures
AU$0.00
AUD
Annual Cash Flow Reinvestment Rate for Inhalerx Ltd (None–None)
Year-by-year capital reinvestment analysis for Inhalerx Ltd. For live market cap and broader valuation context, see IRX stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (AUD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow